Andrew Di Piero
About Andrew Di Piero
Andrew Di Piero is the Senior Global Trial Manager for Oncology Clinical Protocol Operations at Bristol Myers Squibb, with over 15 years of experience in clinical trial management.
Current Role at Bristol Myers Squibb
Andrew Di Piero currently holds the position of Senior Global Trial Manager, Oncology Clinical Protocol Operations at Bristol Myers Squibb. In this capacity, he oversees global clinical trials focusing on oncology, managing trial execution, and ensuring compliance with protocols. His role involves coordinating with various stakeholders to advance oncology clinical research.
Previous Experience at Bristol Myers Squibb
Before his current role, Andrew Di Piero worked as a Protocol Manager in the Oncology Clinical Protocol Operations at Bristol Myers Squibb from 2018 to 2020. During this two-year period, he was responsible for developing and managing clinical protocols for oncology trials, ensuring that all trial processes adhered to regulatory standards and scientific requirements.
Experience at Syneos Health
From 2017 to 2018, Andrew Di Piero served as a Project Manager, Oncology at Syneos Health (previously known as INC Research/inVentiv Health). In this role, he managed oncology clinical trials, collaborating with clinical research teams and ensuring that project goals were met within specified timelines and budgets.
Work at ExecuPharm
Between 2015 and 2017, Andrew Di Piero was a Senior Clinical Scientist, Oncology at ExecuPharm. His responsibilities included overseeing the clinical aspects of oncology trials, analyzing clinical data, and contributing to the scientific integrity of the trials. He played a key role in ensuring that clinical activities were conducted in accordance with regulatory and ethical standards.
Early Career and Transition to Oncology
Andrew Di Piero's career in clinical trial management began at ERT, where he worked as a Project Manager focusing on cardiac safety from 2008 to 2011. He transitioned to oncology clinical trials in 2011 when he joined Quintiles as a Project Manager. Since then, he has cemented his expertise in oncology, holding roles at UBC - An Express Scripts Company, Syneos Health, and Bristol Myers Squibb, where he has contributed to numerous oncology clinical trials.
Educational Background
Andrew Di Piero completed his undergraduate education at Ithaca College, attending from 1999 to 2003. His academic foundation has supported his extensive career in clinical trial management, particularly in the field of oncology.